These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38835923)

  • 1. Piperacillin/Tazobactam Use vs Cefepime May Be Associated With Acute Decompensated Heart Failure.
    Scheerenberger HR; Kullab S; Elgazzar A; Lewis N; Shams WE
    Fed Pract; 2024 Feb; 41(2):44-47. PubMed ID: 38835923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin With Concomitant Piperacillin/Tazobactam vs. Cefepime or Meropenem Associated Acute Kidney Injury in General Ward Patients: A Multicenter Propensity Score-Matched Study.
    Komerdelj IA; Buckley MS; D'Alessio PA; Ziadat DS; Kobic E; Rangan P; Agarwal SK; Tinta NC; Yerondopoulos MJ; Kane-Gill SL
    J Pharm Pract; 2024 Feb; 37(1):80-87. PubMed ID: 36075000
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit.
    Buckley MS; Hartsock NC; Berry AJ; Bikin DS; Richards EC; Yerondopoulos MJ; Kobic E; Wicks LM; Hammond DA
    J Crit Care; 2018 Dec; 48():32-38. PubMed ID: 30172962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial.
    Qian ET; Casey JD; Wright A; Wang L; Shotwell MS; Siemann JK; Dear ML; Stollings JL; Lloyd BD; Marvi TK; Seitz KP; Nelson GE; Wright PW; Siew ED; Dennis BM; Wrenn JO; Andereck JW; Han JH; Self WH; Semler MW; Rice TW;
    JAMA; 2023 Oct; 330(16):1557-1567. PubMed ID: 37837651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Seo YB; Lee J; Kim YK; Lee SS; Lee JA; Kim HY; Uh Y; Kim HS; Song W
    BMC Infect Dis; 2017 Jun; 17(1):404. PubMed ID: 28592240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    LeCleir LK; Pettit RS
    Pediatr Pulmonol; 2017 Aug; 52(8):1000-1005. PubMed ID: 28440913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients.
    Chen AY; Deng CY; Calvachi-Prieto P; Armengol de la Hoz MÁ; Khazi-Syed A; Chen C; Scurlock C; Becker CD; Johnson AEW; Celi LA; Dagan A
    Chest; 2023 Aug; 164(2):355-368. PubMed ID: 37040818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison Between Cefepime and Piperacillin-Tazobactam in the Management of Septic Shock.
    Ross RC; Rosen AN; Tran KK; Smith KL; Franck AJ
    Cureus; 2021 Oct; 13(10):e18742. PubMed ID: 34790489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Cohort Study of the Incidence of Acute Kidney Injury with Vancomycin Area under the Curve-Based Dosing with Concomitant Piperacillin-Tazobactam Compared to Meropenem or Cefepime.
    Kiley PS; Pearston AP; Hodge LA; Kaplan MC; Baczek SM; Stanley JS; Wilson TJ; Soriano KM; Yao A; Shaeffer ZA; Talt IE; Cohen JA; Ingemi AI
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0004022. PubMed ID: 35867523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.
    Clemmons AB; Bech CF; Pantin J; Ahmad I
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):820-826. PubMed ID: 29292056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
    Mullins BP; Kramer CJ; Bartel BJ; Catlin JS; Gilder RE
    Ann Pharmacother; 2018 Jul; 52(7):639-644. PubMed ID: 29442542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric drug utilization evaluation of cefepime and piperacillin/tazobactam.
    Prasopchoknapaporn P; Boonsathorn S; Techasaensiri C; Chaisavaneeyakorn S; Apiwattanakul N
    Pediatr Int; 2022 Jan; 64(1):e15276. PubMed ID: 36257611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
    Kaye KS; Belley A; Barth P; Lahlou O; Knechtle P; Motta P; Velicitat P
    JAMA; 2022 Oct; 328(13):1304-1314. PubMed ID: 36194218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime.
    Chanderraj R; Admon AJ; He Y; Nuppnau M; Albin OR; Prescott HC; Dickson RP; Sjoding MW
    JAMA Intern Med; 2024 Jul; 184(7):769-777. PubMed ID: 38739397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
    Schreier DJ; Kashani KB; Sakhuja A; Mara KC; Tootooni MS; Personett HA; Nelson S; Rule AD; Steckelberg JM; Tande AJ; Barreto EF
    Clin Infect Dis; 2019 Apr; 68(9):1456-1462. PubMed ID: 30165426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem.
    Holsen MR; Wardlow LC; Bazan JA; Fussner LA; Coe KE; Elefritz JL
    Int J Antimicrob Agents; 2019 Dec; 54(6):824-828. PubMed ID: 31319191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Prevalence of Acute Kidney Injury in Chinese Patients Receiving Vancomycin with Concurrent β-Lactam Antibiotics: A Retrospective Cohort Study.
    Liu K; Zhang Y; Xu X; Wu B; Ni J; Li T; Xing C; Mao H
    Clin Ther; 2021 Oct; 43(10):e319-e351. PubMed ID: 34579971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia.
    Kim BG; Kang D; Min KH; Cho J; Jeon K
    Antibiotics (Basel); 2023 May; 12(6):. PubMed ID: 37370303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of acute kidney injury in patients prescribed vancomycin in combination with piperacillin-tazobactam or cefepime for diabetic foot infections.
    Piccuirro SR; Casapao AM; Claudio AM; Isache C; Jankowski CA
    J Investig Med; 2021 Jan; ():. PubMed ID: 33495283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.